International Programming Highlights

For those looking to take advantage of all the Convention has to offer, specifically within the international programming, you have landed in the right spot. Take a few minutes to review our international programming highlights. For more information, visit myBIO and map your day out!

International Programming Highlights –MONDAY

Global Biotechnology Forum: The BRICs and Beyond

10:00 – 11:30 a.m., Room 259 B

The Global Biotechnology Forum: The BRICs and Beyond will explore how governments of major emerging markets are responding to the need to bridge funding gaps for the next generation of cutting-edge innovations.

Speakers include: the Honourable Nihat Ergun, Minister of Science, Industry & Technology, Turkey; the Honourable Naledi Pandor, Minister of Science & Technology, South Africa and the Honourable Lino Barañao, Minister of Science, Technology, & Innovative Production, Argentina

China Day: Biotechnology in the Middle Kingdom: A New Plan, A Renewed Focus, A One Billion Person Promise

9:00 a.m. – 5:30 p.m.

A full-day of programming, dedicated to China has been developed to target both Chinese and Western delegations.

The Chinese Delegation programming for both private industry and government ministries includes a local facility tour; Chinese-national focused panels and networking events.

The parallel, Western Delegation programming, is targeted towards Western businesses doing business in China and takes an in-depth look at healthcare innovation in China, the 12th Five-year Plan and navigation of the Chinese government reimbursement procedure.

International Case Studies Educational Track

Life Sciences to Market: Supporting Innovative Healthcare in Europe

8:30-9:15 a.m., Room 254 A

Moderator: Alexandre Delacoux, Executive Director, European Biopharmaceutical Enterprises

Speakers: Hilde Boone, European Medicines Agency Liaison Official at U.S., European Medicines Agency, Thomas Heynisch, Deputy Head of Unit Healthcare, Biotechnology, European Commission, DG Enterprise and Industry and Arnd Hoeveler, Head of Unit, European Commission, DG Research and Innovation

Bringing Life Sciences to the Market: the European Approach to Bioeconomy

9:30-10:15 a.m., Room 254 A

Moderator: Thomas Heynisch, Deputy Head of Unit Healthcare, Biotechnology, European Commission, DG Enterprise and Industry

Speakers: Nathalie Moll, Secretary General, EuropaBio and Barend Verachtert, Deputy Head of Unit, European Commission DG Research

Health Policy and Reimbursement Educational Track

Access to and Uptake of Biosimilars: The European Experience

10:00-11:30 a.m., Room 252 A

Moderator: Thomas Heynisch, Deputy Head of Unit Healthcare, Biotechnology, European Commission, DG Enterprise and Industry

Speakers: Thomas Bols, Vice President Health Policy & Market Access, Merck Serono, Hilde Boone, European Medicines Agency Liaison Official at U.S., European Medicines Agency, Paul Greenland, Biosimilars and Proprietary Marketing Director – E, Hospira UK Limited and Steffen Thirstrup, Chief Medical Officer, Danish Medicines Agency (DKMA)

International Programming Highlights –TUESDAY

International Leaders Share Their Worldview: Scientific American’s Regional Bio-Innovation Scorecard

3:45 – 5:15 p.m., Room 210 ABC

What are the BRICS of the future? Scientific American’s 2012 Worldview will contain a special section on Emerging Markets 2.0 and an exploration of countries that are showing promise for future development and an on-the-ground look at some of the science parks, incubators, research centers, or other hot spots of innovation that are coming into their own.

Moderator:  Fareed Zakaria, CNN host, Editor-at-Large of TIME Magazine, Washington Post columnist and New York Times bestselling author

Speakers: The Honourable Naledi Pandor, Minister of Science & Technology, South Africa and Kiran Mazumdar Shaw, Chairman & Managing Director, Biocon Ltd.

Global Innovations and Markets Educational Track

Increasing Cancer Drug Availability in Resource-Limited Settings: Models for the Future

10:00 – 11:30 a.m., Room 256

Speakers: Pierre Anhoury, Senior Executive, Accenture, Jean-Francois Baladi, Executive Director, Health Economics and Pricing, Novartis Pharmaceuticals, Salim Shah, Chief Scientist, Georgetown University Medical Center and Bhadrasain Vikram, Branch Chief, Clinical Radiation Oncology Branch, National Cancer Institute

International Solutions to Pandemic Problems – It Takes More Than Just a Village

2:00 – 3:30 p.m., Room 258 B

Moderators: Stacey Nunes, Business Development Officer, National Research Council Canada

Speakers: Cecilia Banuelos Barron, Director, Division of Research on Health and Environment, Institute of Science and Technology of Mexico City, Luis Barreto, President, Dr. Luis Barreto and Associates, Francisco Diaz-Mitoma, CEO and Chief Scientific Officer, Advanced Medical Research Institute of Canada and Mauricio Rodriguez, General Director, National Center for Bioinformatics and Computation

Innovative Approaches to Financing R&D for Global Health

3:45 – 5:00 pm., Room 256

Speakers: Labeeb Abboud, Senior Vice President & General Counsel, International AIDS Vaccine Initiative, Andrew Farnum, Senior Program Investment Officer, Bill & Melinda Gates Foundation, Neal Fowler, CEO, Liquida and Glenn Rockman, Vice President, Social Finances, JP Morgan

International Programming Highlights –WEDNESDAY

International Reception

5:00 – 6:30 p.m., Ballroom Prefunction

The reception will begin with a presentation by Scientific American, hosting an interactive discussion in which the 2012 Worldview Scorecard and hottest regions in biotechnology will be highlighted.

Sponsored by Andrews Kurth LLP

Global Innovations and Markets Educational Track

Emerging Markets Become Strategic Markets: Biotechs Looking Internationally for R&D, Manufacturing and Market Opportunities

10:00 – 11:30 a.m., Room 256

Moderators: Amir Nashat, General Partner, Polaris Venture Partners

Speakers: Werner Cautreels, President and CEO, Selecta Biosciences, Scott Minick, President and CEO, Bind Biosciences, Inc., Nikolay Savchuk, Chairman, ChemDiv Research Institute and Curtis Tyree, VP, Operations, Huya Bioscience International

Stem Cell Therapies…Fact or Fiction?

3:00 p.m. – 3:45 p.m., Room 254 A

Moderator: James Reid, CEO, Sistemic

Speakers: Chris Airriess, COO, California Stem Cell and Eduardo Bravo, CEO, TiGenix

Events  |  Email This Post  |  Printer Friendly
Tags: , , ,

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>